xmlns:atom="http://www.w3.org/2005/Atom" xmlns:atom="http://www.w3.org/2005/Atom"

ANNEXU.K.

(a) Applicant and Authorisation holder U.K.

Name

:

Monsanto Europe S.A.

Address

:

Avenue de Tervuren 270-272, 1150 Brussels, Belgium

On behalf of Monsanto Company, United States.

(b) Designation and specification of the products U.K.

Pollen produced from MON-ØØ81Ø-6 maize, as or in foods and food ingredients.

The genetically modified MON-ØØ81Ø-6 maize, as described in the application, expresses the Cry1Ab protein which confers protection against certain lepidopteran pests.

(c) Labelling U.K.

For the purposes of the specific labelling requirements laid down in Article 13(1) of Regulation (EC) No 1829/2003, the ‘name of the organism’ shall be ‘maize’.

(d) Method for detection U.K.

(e) Unique identifier U.K.

MON-ØØ81Ø-6

(f) Information required under Annex II to the Cartagena Protocol on Biosafety to the Convention on Biological Diversity U.K.

Not required.

(g) Conditions or restrictions on the placing on the market, use or handling of the products U.K.

Not required.

(h) Monitoring plan U.K.

Not required.

(i) Post market monitoring requirements for the use of the food for human consumption U.K.

Not required.

Note: links to relevant documents may need to be modified over the time. Those modifications will be made available to the public via the updating of the Community register of genetically modified food and feed.U.K.